Загрузка...
An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysis
In the U.S., pneumococcal polysaccharide vaccine (PPSV23) uptake among high-risk adults aged <65 years is consistently low and improvement is needed. One barrier to improved vaccine coverage is the complexity of the adult vaccination schedule. This exploratory analysis compared the cost-effective...
Сохранить в:
| Опубликовано в: : | Hum Vaccin Immunother |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6605822/ https://ncbi.nlm.nih.gov/pubmed/30633706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1564439 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|